Resource Capital Fund IV L.P. Disposes of Shares of EMED Mining Public Limited pursuant to Share Purchase Agreement

DENVER, July 30, 2014 /CNW/ - Resource Capital Fund IV L.P. ("RCF IV") reports that it has entered into a share purchase agreement with a third party (the "Agreement") with respect to the 167,022,016 ordinary shares in the capital of EMED Mining Public Ltd. (the "Subject Shares") held by RCF IV. 

Pursuant to the terms of the Agreement, RCF IV sold the Subject Shares to the third party for aggregate consideration of £15,031,981.44 or £0.09 per Subject Share, subject to adjustment in certain circumstances.

Prior to entering in to the Agreement, RCF IV's ownership of the Subject Shares represented approximately 13.3% of the issued share capital of EMED. As a result of the sale of the Subject Shares pursuant to the Agreement, RCF IV no longer owns any shares in the capital of EMED.

The Subject Shares were disposed of for investment purposes. RCF IV may in the future decide to invest in the share capital of EMED and, if so, RCF IV will evaluate any future investment in EMED from time to time and may, based on such evaluation of market conditions and other circumstances, increase or decrease shareholdings in EMED as circumstances require.

For further information and to obtain a copy of the early warning report filed under applicable Canadian securities laws in connection with the transactions hereunder, please see EMED's profile on the SEDAR website

SOURCE: Resource Capital Fund IV L.P.

For further information: and to obtain a copy of the early warning report, please contact: Resource Capital Fund IV L.P., 1400 Sixteenth Street, Suite 200, Denver, CO, 80202, Telephone: (720) 946-1444, Attn: Molly Campbell

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890